Anti-aggregation therapy for prevention of cerebral ischemic stroke: a risk benefit analysis
Zarranz Imirizaldu, J.J.
Medicina Clinica 109(20): 802-807
1997
ISSN/ISBN: 0025-7753 PMID: 9493161 Document Number: 470826
Document emailed within 1 workday
Related Documents
Honczarenko, K.; Torbus-Lisiecka, B.; Osuch, Z.; Nocoń, D.; Nowacki, P.; Potemkowski, A.; Narolewska, A. 1999: Fibrinogen and lipids: associated risk factors for ischemic cerebral stroke Neurologia i Neurochirurgia Polska 33(3): 557-565Arjona, A.; Bartolomé, M.T.; Mata, M.; Corral, F.; Blasco, M.R.; Jiménez, C. 1997: Idiopathic multiple cerebral hemorrhage: are platelet anti-aggregation agents a risk factor? Revista de Neurologia 25(148): 2069
Kamchatov, P.R.; Chugunov, A.V.; Umarova, K.Ia. 2008: Antiaggregation therapy is a secondary prevention of ischemic stroke Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova Suppl. 23: 58-64
Yao, X.-y.; Lin, Y.; Geng, J.-l.; Sun, Y.-m.; Chen, Y.; Li, Y.-s. 2012: An analysis of risk factors for ischemic stroke of different age and gender Zhonghua Nei Ke Za Zhi 51(8): 630-633
Demarin, V.; Lovrencić-Huzjan, A.; Serić, V.; Vargek-Solter, V.; Trkanjec, Z.; Vuković, V.; Lupret, V.; Kalousek, M.; Desyo, D.; Kadojić, D.; Lusić, I.; Dikanović, M.; Vitas, M. 2003: Recommendations for management of patients with cerebral stroke. Part Two: Primary and secondary prevention of cerebral stroke Lijecnicki Vjesnik 125(11-12): 322-328
Woloszynska, I.; Stfpien, A. 2017: Risk Factors of Rt-Pa Therapy in Patients with Ischemic Stroke Acta Poloniae Pharmaceutica 74(1): 293-298
El-Amrani, M.; Aidi, S.; Amarenco, P. 2003: Cerebral ischemic events and anti-cancer therapy Revue Neurologique (Paris) 159(4): 371-380
Riazantsev, A.K. 1985: Effect of ultrahigh-frequency electric fields on cerebral circulation and thrombocyte aggregation in patients with sequelae of cerebral stroke Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 4: 27-29
Busch, M.; Masuhr, F. 2004: Thromboprophylaxis and early antithrombotic therapy in patients with acute ischemic stroke and cerebral venous and sinus thrombosis European Journal of Medical Research 9(4): 199-206
Bertelli, M.; Luongo, R.; Barcella, L.; Cavalli, P. 2008: Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach? Panminerva Medica 50(3): 260-261
Wang, Z.; Shi, Y.; Wang, A.; Wang, C.; Wang, Y. 2014: An analysis of risk factors and their prognostic effects on Chinese women's outcomes after ischemic stroke Zhonghua Nei Ke Za Zhi 53(9): 706-709
Xu, Z.; Li, Y.; Tang, S.; Huang, X.; Chen, T. 2015: Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies Thrombosis Research 136(1): 52-60
Shimokhina, N.I.; Petrova, M.M.; Savchenko, A.A. 2010: Aggregation activity of platelets in various periods of ischemic stroke Kardiologiia 50(8): 21-24
Yanagawa, Y.; Ogura, M.; Okuda, E.; Okunaga, T.; Takahata, H.; Nakamura, M. 2003: A case of moyamoya disease diagnosed by cerebral ischemic symptoms induced by anti-hypertensive therapy No Shinkei Geka. Neurological Surgery 31(3): 275-279
Lin, Y.; Li, Y-Sheng.; Xu, Q.; Shi, G-Wen.; Li, H-Wei.; Geng, J-Li. 2007: The impact of stroke clinic on improving the compliance with the guidelines for secondary prevention of ischemic stroke Zhonghua Nei Ke Za Zhi 46(9): 736-739
Kotwica, Z.; Persson, L.; Hârdemark, H.G.; Pâhlman, S. 1989: Usefulness of determining the level of neuron-specific enolase (NSE) in the cerebrospinal fluid as a biochemical indicator of the extent of cerebral ischemic stroke. Experimental study of the rat model of stroke Neurologia i Neurochirurgia Polska 23(3): 198-202
Kirshner, H.S. 1996: Medical revolution: the prevention and treatment of stroke, 1996. Part 2. Medical prevention of stroke and acute stroke therapy Tennessee Medicine: Journal of the Tennessee Medical Association 89(11): 410-412
Ishchenko, M.M.; Hara, I.I. 1995: The effect of diltiazem on systemic and cerebral hemodynamics and on the blood rheological properties in patients with ischemic stroke and atherosclerotic involvement of the major cerebral arteries Likars'ka Sprava 1995(9-12): 127-131
Eriksson, M.; Jonsson, F.; Appelros, P.; Asberg, K.H.; Norrving, B.; Stegmayr, B.; Terént, A.; Asplund, K. 2011: Emergency thrombolysis in ischemic stroke disseminated over the country. there are still marked regional variations according to Riks-Stroke analysis Lakartidningen 108(1-2): 21-25
Gotti, B.; Duverger, D.; Bertin, J.; Carter, C.; Dupont, R.; Frost, J.; Gaudilliere, B.; MacKenzie, E.T.; Rousseau, J.; Scatton, B. 1988: Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia Journal of Pharmacology and Experimental Therapeutics 247(3): 1211-1221